Viatris Inc. VTRS
17.83
0.41
2.35%
as of 25 Sep
- Market cap
- $20.0B
- P/E
- 0.0×
Follow VTRS
Indexes
indicate stock being part of an index,
Growth Flags
show if company had growth for consecutive years
Viatris Inc. (VTRS) Free cash flow
Viatris Inc.'s free cash flow for fiscal 2025 was $1.9B, down 56.6% from $4.5B in fiscal 2024. Over the twelve months to 30 June 2026 it was $1.9B. Over the past ten years it has ranged from $552.7M (fiscal 2020) to $4.5B (fiscal 2024); the current reading is higher than 64% of that period. Viatris Inc. ranks 4th of 86 Drug Manufacturers Specialty & Generic companies by free cash flow.
Free cash flow, annual
Annual
| Period | Free cash flow | Change |
|---|---|---|
| FY2025 | $1.9B | (56.58%) |
| FY2024 | $4.5B | 59.29% |
| FY2023 | $2.8B | 9.10% |
| FY2022 | $2.6B | 1.74% |
| FY2021 | $2.5B | 356.99% |
| FY2020 | $552.7M | (61.23%) |
| FY2019 | $1.4B | 21.29% |
| FY2018 | $1.2B | (6.37%) |
| FY2017 | $1.3B | (3.19%) |
| FY2016 | $1.3B | 13.83% |
Quarterly
| Period | Free cash flow | Change |
|---|---|---|
| Jun 2026 | $336.2M | 25.45% |
| Mar 2026 | $268.0M | (58.15%) |
| Dec 2025 | $640.4M | (0.87%) |
| Sep 2025 | $646.0M | 286.36% |
| 42 more quarters | Free account |
Against its own ten years
Low $552.7M
High $4.5B
Ten-year median
$1.4B
Current reading's percentile
64
Free cash flow against peers
| Company | Free cash flow |
|---|---|
| HLN Haleon PLC Sponsored ADR compare | $4.6B |
| ZTS Zoetis Inc. compare | $2.3B |
| VTRS Viatris Inc. | $1.9B |
| TEVA Teva Pharmaceutical Industries Ltd. compare | $1.4B |
| UTHR United Therapeutics Corporation compare | $1.1B |
| NBIX Neurocrine Biosciences, Inc. compare | $870.4M |
| ELAN Elanco Animal Health Incorporated compare | $379.0M |
| RDY Dr. Reddy's Laboratories Ltd compare | $139.0M |
| HIMS Hims & Hers Health, Inc. compare | $83.0M |
What Free cash flow is
Free Cash Flow tells an investor how much cash a company’s operations generate after paying for its investment in physical and intangible assets.
Operating Cash Flow + Property, Plant, Equipment Change (Net) + Intangible Assets Change (Net)
More on VTRS
- Revenue
- Net income
- EBITDA
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement